文献速递神经外周血管头颈MR

颅外颈动脉动脉瘤瘤壁钆增强影像研究

Gadolinium Enhancement of the Aneurysm Wall in Extracranial Carotid Artery Aneurysms.
PubMed 文献 · AJNR Am J Neuroradiol · 2020-02-27

本研究对14例保守治疗的无症状颅外颈动脉动脉瘤患者(15个动脉瘤)进行间隔12个月的两次3T钆增强MR成像,评估瘤壁增强与动脉瘤生长及脑梗死/白质病变的关系。结果显示瘤壁成像可行,15个动脉瘤中11个(73%)基线有钆增强,4个(27%)随访增大(增强阳性2个 vs 阴性2个,P=0.245);作者认为需未来充分把握度的研究验证瘤壁增强能否预测生长和血栓栓塞并发症。

要点

  • 颅外颈动脉动脉瘤瘤壁钆增强在3T MR上可行,15个动脉瘤中11个(73%)基线显示增强。
  • 随访4个动脉瘤(27%)增大,增强阳性2个 vs 增强阴性2个(P=0.245),未达统计学显著。
  • 基线3例(21%)有同侧脑梗死,随访1例增强阳性者出现新发无症状脑梗死。

核心结论

  • 本探索性研究显示颅外颈动脉动脉瘤瘤壁成像可行,未来需充分把握度的研究验证瘤壁钆增强能否预测动脉瘤生长和血栓栓塞并发症。

研究设计与样本

  • 探索性研究,纳入14例保守治疗的无症状颅外颈动脉动脉瘤患者共15个动脉瘤,行3T钆增强MR成像,间隔12个月两个时间点。
  • 主要结局为动脉瘤囊生长(≥2.0 mm),次要结局为基线和随访时(无症状)脑梗死及白质病变的存在。
  • MR图像由2名独立观察者判读,评估观察者间和观察者内可重复性。

关键影像表现/征象

  • 11个(73%)动脉瘤为囊状(中位大小11 mm,范围5.0-38.5 mm),4个为梭形(中位大小21.5 mm,范围10.0-40.0 mm)。
  • 15个动脉瘤中11个(73%)基线显示钆增强。
  • 随访4个动脉瘤(27%)增大,其中钆增强阳性2个、钆增强阴性2个(P=0.245)。
  • 基线3例患者(21%)有同侧脑梗死,随访其中1例(钆增强阳性)出现新发无症状脑梗死;基线9例(64%)有双侧白质病变,随访3例白质病变严重程度增加(2例钆增强阳性)。
  • 所有观察均显示极好的观察者间和观察者内可重复性。

诊断标准与关键数值

  • 动脉瘤囊生长定义为≥2.0 mm。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文为探索性研究,未来需充分把握度的研究验证颅外颈动脉动脉瘤钆增强是否预测动脉瘤生长和血栓栓塞并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: The natural history and optimal treatment of extracranial carotid artery aneurysms are unknown. Gadolinium enhancement of the aneurysm wall may reflect aneurysm wall inflammation and instability. In this study, we investigated the feasibility of extracranial carotid artery aneurysm wall imaging and explored a potential relationship of aneurysm wall enhancement with aneurysm growth and the presence of (silent) brain infarcts and white matter lesions.

MATERIALS AND METHODS: Fourteen conservatively treated patients with 15 asymptomatic extracranial carotid artery aneurysms underwent gadolinium-enhanced 3T MR imaging at 2 time points with a 12-month interval. Primary outcome was growth of the aneurysm sac (≥2.0 mm); secondary outcomes were the presence of (silent) brain infarcts and white matter lesions at baseline and follow-up. MR images were reviewed by 2 independent observers, and inter- and intraobserver reproducibility was assessed.

RESULTS: Seven (50%) patients were men; the median age was 55 years (range, 40-69 years). Eleven extracranial carotid artery aneurysms (73%) were saccular (median size, 11 mm; range, 5.0-38.5 mm), and 4 were fusiform (median size, 21.5 mm; range, 10.0-40.0 mm). Eleven of 15 aneurysms (73%) exhibited gadolinium enhancement at baseline. Four aneurysms (27%) showed growth at follow-up imaging, 2 gadolinium-positive (+) and 2 gadolinium-negative (-) (P = .245). Three patients (21%) had ipsilateral brain infarcts at baseline; 1 of them showed a new silent brain infarct at follow-up imaging (gadolinium+). Nine patients (64%) showed bilateral white matter lesions at baseline. In 3 patients, increased white matter lesion severity was observed at follow-up (2 gadolinium+). All observations showed excellent inter- and intraobserver reproducibility.

CONCLUSIONS: In this explorative study, we demonstrated that extracranial carotid artery aneurysm wall imaging was feasible. Future well-powered studies are needed to investigate whether extracranial carotid artery aneurysm gadolinium enhancement predicts aneurysm growth and thromboembolic complications.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. van Laarhoven CJHCM, Rots ML, Pourier VEC, et al. Gadolinium Enhancement of the Aneurysm Wall in Extracranial Carotid Artery Aneurysms. AJNR Am J Neuroradiol. 2020. PMID: 32115417. doi:10.3174/ajnr.A6442

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。